U.S., March 31 -- ClinicalTrials.gov registry received information related to the study (NCT07499050) titled 'A Study of Multiple Doses of Orally Administered RO7795081 in Otherwise Healthy Chinese Adult Participants With Obesity or Overweight' on March 23.
Brief Summary: This is an investigator- and participant-blind, randomized, placebo-controlled, parallel-group, Phase I study evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple doses of orally administered RO7795081 in otherwise healthy Chinese adult participants with obesity or overweight.
Study Start Date: March 31
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers
Overweight or Obesity
Intervention:
DRUG: RO7795081
RO7795081 will be ad...